Parexel to acquire functional service provider ExecuPharm

By Melissa Fassbender contact

- Last updated on GMT

Parexel has entered into a definitive agreement to acquire ExecuPharm. (Image: iStock/Ridofranz)
Parexel has entered into a definitive agreement to acquire ExecuPharm. (Image: iStock/Ridofranz)

Related tags: Pharmaceutical industry

Parexel has entered into a definitive agreement to acquire ExecuPharm, a global functional service provider (FSP), in a deal that it said will add scale to meet growing demand.

King of Prussia, PA-based ExecuPharm​ provides clients with professionals in several areas, such as clinical monitoring or study management. The company also provides support with operational activities, including onboarding, training, line management, performance management, and policy administration.

"Functional services represent an established and growing model within the biopharmaceutical industry, and ExecuPharm has supported the growing demand for these services," ​Cristi L. Barnett, senior director, global public relations, Parexel, told Outsourcing-Pharma.com, adding that both companies see "continued FSP growth opportunities​."

According to the company, ExecuPharm has seen an 85% growth over the past three years, while working with many top 20 and mid-sized and small biopharma companies.

Josef von Rickenbach, Chairman and CEO, Parexel, explained that clients are increasingly using both programmatic and functional outsourcing models, in the company's press release issued this morning. 

With its acquisition of ExecuPharm, Rickenbach said its existing functional services offering and capabilities will be expanded in order to meet the growing market demand – allowing clients to “fulfill all of their clinical development outsourcing needs through a single company​.”

The acquisition, terms of which were not released, is expected to close in the next three weeks.

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 20-Jun-2022 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

What the Best Clinical Study Build Pros Do

What the Best Clinical Study Build Pros Do

Formedix | 09-May-2022 | Technical / White Paper

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you've got to do all your CRF designs;...

Related suppliers

Follow us

Products

View more

Webinars